These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 9207297)

  • 1. Fas and the immunologically underprivileged intestine.
    Ma A
    Gastroenterology; 1997 Jul; 113(1):345-8. PubMed ID: 9207297
    [No Abstract]   [Full Text] [Related]  

  • 2. Fas-induced apoptosis.
    Nagata S
    Intern Med; 1998 Feb; 37(2):179-81. PubMed ID: 9550601
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunoregulatory effects of Fas-mediated signalling.
    Lynch DH; Alderson MR; Ramsdell F
    J Cell Biochem; 1996 Jan; 60(1):39-46. PubMed ID: 8825414
    [No Abstract]   [Full Text] [Related]  

  • 4. Differential contribution of Fas- and perforin-mediated mechanisms to the cell-mediated cytotoxic activity of naive and in vivo-primed intestinal intraepithelial lymphocytes.
    Corazza N; Müller S; Brunner T; Kägi D; Mueller C
    J Immunol; 2000 Jan; 164(1):398-403. PubMed ID: 10605035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional Fas and Fas-ligand activities in activated T cells of kidney transplant recipients.
    Nakajima H; Oka T
    Transplant Proc; 1997 Sep; 29(6):2533-4. PubMed ID: 9290729
    [No Abstract]   [Full Text] [Related]  

  • 6. The Fas counterattack: cancer as a site of immune privilege.
    O'Connell J; Bennett MW; O'Sullivan GC; Collins JK; Shanahan F
    Immunol Today; 1999 Jan; 20(1):46-52. PubMed ID: 10081230
    [No Abstract]   [Full Text] [Related]  

  • 7. Induction of Jurkat T-cell apoptosis by Fas ligand-transfected endothelial cells.
    Cappellesso S; Thibault G; Hoarau C; Watier H; Bardos P; Lebranchu Y
    Transplant Proc; 2000 Dec; 32(8):2737-8. PubMed ID: 11134778
    [No Abstract]   [Full Text] [Related]  

  • 8. Defining the roles of perforin, Fas/FasL, and tumour necrosis factor alpha in T cell induced mucosal damage in the mouse intestine.
    Merger M; Viney JL; Borojevic R; Steele-Norwood D; Zhou P; Clark DA; Riddell R; Maric R; Podack ER; Croitoru K
    Gut; 2002 Aug; 51(2):155-63. PubMed ID: 12117872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Die and let live: eliminating dangerous lymphocytes.
    Abbas AK
    Cell; 1996 Mar; 84(5):655-7. PubMed ID: 8625402
    [No Abstract]   [Full Text] [Related]  

  • 10. Analysis of biochemical and biological functions of Fas-ligand (FasL) and Fas on activated T cells in allo-immune response.
    Nakajima H; Oka T
    Transplant Proc; 1997; 29(1-2):1096-100. PubMed ID: 9123217
    [No Abstract]   [Full Text] [Related]  

  • 11. Fas-ligand: privilege and peril.
    Green DR; Ware CF
    Proc Natl Acad Sci U S A; 1997 Jun; 94(12):5986-90. PubMed ID: 9177153
    [No Abstract]   [Full Text] [Related]  

  • 12. Cell death induced by the Fas/Fas ligand pathway and its role in pathology.
    Waring P; Müllbacher A
    Immunol Cell Biol; 1999 Aug; 77(4):312-7. PubMed ID: 10457197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zeta-associated protein of 70 kDa (ZAP-70), but not Syk, tyrosine kinase can mediate apoptosis of T cells through the Fas/Fas ligand, caspase-8 and caspase-3 pathways.
    Zhong L; Wu CH; Lee WH; Liu CP
    J Immunol; 2004 Feb; 172(3):1472-82. PubMed ID: 14734724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of apoptosis following antigen presentation by T cells: anergy and apoptosis are two separate phenomena.
    Hargreaves RG; Borthwick NJ; Gilardini Montani MS; Piccolella E; Carmichael P; Lechler RI; Akbar AN; Lombardi G
    Transplant Proc; 1997; 29(1-2):1102-4. PubMed ID: 9123219
    [No Abstract]   [Full Text] [Related]  

  • 15. Life (and death) in the Fas lane.
    Akbar AN
    Gut; 1998 Jul; 43(1):5-6. PubMed ID: 9771397
    [No Abstract]   [Full Text] [Related]  

  • 16. Fas ligand-induced c-Jun kinase activation in lymphoid cells requires extensive receptor aggregation but is independent of DAXX, and Fas-mediated cell death does not involve DAXX, RIP, or RAIDD.
    Villunger A; Huang DC; Holler N; Tschopp J; Strasser A
    J Immunol; 2000 Aug; 165(3):1337-43. PubMed ID: 10903735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Apoptosis mediated by Fas and its related diseases].
    Nagata S
    Nihon Ika Daigaku Zasshi; 1997 Oct; 64(5):459-62. PubMed ID: 9366151
    [No Abstract]   [Full Text] [Related]  

  • 18. Induction of apoptosis in human mitogen-activated peripheral blood T-lymphocytes by the ether phospholipid ET-18-OCH3: involvement of the Fas receptor/ligand system.
    Cabaner C; Gajate C; Macho A; Muñoz E; Modolell M; Mollinedo F
    Br J Pharmacol; 1999 Jun; 127(4):813-25. PubMed ID: 10433487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the role and significance of Fas (Apo-1/CD95) ligand (FasL) expression in immune privileged tissues and cancer cells using multiple myeloma as a model.
    Greil R; Egle A; Villunger A
    Leuk Lymphoma; 1998 Nov; 31(5-6):477-90. PubMed ID: 9922038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apoptosis and CD95 ligand in immune privileged sites.
    Bellgrau D; Duke RC
    Int Rev Immunol; 1999; 18(5-6):547-62. PubMed ID: 10672501
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.